Market Overview

20 Biggest Mid-Day Losers For Monday

Share:
  • Ocera Therapeutics Inc (NASDAQ: OCRX) shares dropped 68.3 percent to $0.650 after the company reported top-line results for Phase 2b study in Hepatic Encephalopathy.
  • Regulus Therapeutics Inc (NASDAQ: RGLS) shares declined 50 percent to $1.12 after the company received a written communication from the U.S. Food and Drug Administration that the clinical development for the company's RG-101 remains on clinical hold.
  • Pulmatrix Inc (NASDAQ: PULM) declined 27.9 percent to $2.43 after surging 51.80 percent on Friday. Pulmatrix reported a $5 million registered direct offering.
  • Tempur Sealy International Inc (NYSE: TPX) shares dipped 27.6 percent to $45.74 following announcement of termination of Mattress Firm (NASDAQ: MFRM) contracts.
  • Opus Bank (NASDAQ: OPB) fell 23.9 percent to $20.75. Opus Bank reported a Q4 loss of $0.55 per share.
  • Rite Aid Corporation (NYSE: RAD) dropped 16.4 percent to $5.79. In a merger amendment publicized Monday morning, Walgreens Boots Alliance Inc (NASDAQ: WBA) and Rite Aid agreed to reduce the value of Rite Aid shares between $6.50 and $7 and to divest a total of 1,200 stores. The initial agreement proposed a divestment of 1,000. The companies also announced the extension of the transaction deadline to July 31.
  • Rewalk Robotics Ltd (NASDAQ: RWLK) fell 13 percent to $2.00. Rewalk Robotics shares have declined 77.02 percent over the past 52 weeks, while the S&P 500 index has gained 18.32 percent in the same period.
  • Fitbit Inc (NYSE: FIT) shares tumbled 12.1 percent to $6.34 after the company surprised investors with a downward revision to its fourth-quarter guidance and a plan to slash around 6 percent of its total workforce.
  • Costamare Inc (NYSE: CMRE) declined 10.3 percent to $5.39. Credit Suisse downgraded Costamare from Neutral to Underperform.
  • Globus Maritime Ltd (NASDAQ: GLBS) shares dropped 10 percent to $8.48 after rising 3.51 percent on Friday.
  • Enbridge Energy Partners, L.P. (NYSE: EEP) declined 9.4 percent to $19.33. Mizuho downgraded Enbridge Energy Partners from Buy to Neutral and lowered the price target from $29.00 to $22.00.
  • Booz Allen Hamilton Holding Corporation (NYSE: BAH) dropped 8.3 percent to $33.25 after the company reported weaker-than-expected earnings for its third quarter.
  • Array Biopharma Inc (NASDAQ: ARRY) declined 7.3 percent to $10.38. Leerink Swann downgraded Array Biopharma from Outperform to Market Perform.
  • FibroGen Inc (NASDAQ: FGEN) fell 6.7 percent to $21.75. FibroGen disclosed that FG-4592 has met primary endpoints in two Phase 3 anemia studies in China.
  • Rowan Companies PLC (NYSE: RDC) slipped 6.5 percent to $18.02. Jefferies downgraded Rowan from Buy to Hold.
  • CONSOL Energy Inc. (NYSE: CNX) dropped 6 percent to $17.86. SunTrust Robinson Humphrey downgraded CONSOL Energy from Buy to Hold.
  • Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) shares fell 5.2 percent to $5.13. Baird downgraded Himax from Outperform to Neutral.
  • Novan Inc (NASDAQ: NOVN) dropped 4.8 percent to $4.62 after dipping 74.01 percent on Friday.
  • Paycom Software Inc (NYSE: PAYC) declined 4.6 percent to $46.94. Pacific Crest downgraded Paycom Software from Overweight to Sector Weight.
  • Barclays PLC (ADR) (NYSE: BCS) fell 3 percent to $11.18. Berenberg downgraded Barclays from Hold to Sell.

Latest Ratings for OCRX

DateFirmActionFromTo
Nov 2017DowngradesBuyNeutral
Jan 2017DowngradesMarket OutperformMarket Perform
Dec 2016Initiates Coverage OnBuy

View More Analyst Ratings for OCRX
View the Latest Analyst Ratings

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

 

Related Articles (ARRY + BAH)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NCMIBenchmarkMaintains12.0
FWONAFBN SecuritiesDowngrades
BXCitiDowngrades52.0
TRVBank of AmericaDowngrades
PSTGCross ResearchUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Facebook's Q4: Conference Call Tone Matters More Than Results

There's A New Gold ETF: Here's What You Need To Know